Join Us at the 30th Annual
Interdisciplinary
Breast Center Conference




We are showcasing MammaPrint® and BluePrint® genomic tests for comprehensive profiling of early-stage breast cancer.

Register for the meeting and visit our virtual booth

Click Here to Register Now

Attend our virtual presentation titled:

Genomic Profiling in Early Stage Breast Cancer

Saturday, April 17 12:10 PM PST

William Audeh, MD, MS

Dr. William Audeh is a medical oncologist specializing in breast cancer, with nearly 30 years of experience as a clinician and clinical researcher at the Cedars-Sinai Cancer Center in Los Angeles. Prior to joining Agendia as Chief Medical Officer, and in addition to his clinical practice, he served as the former Director of the Cedars-Sinai Cancer Center and Medical Director of the Wasserman Breast Cancer Risk Reduction Program. Dr. Audeh has been Principal Investigator on a wide variety of national and international clinical and translational trials, and has authored numerous publications in the field of breast cancer, cancer genomics and targeted cancer therapy.

RSVP TODAY
FOR PROVEN RESULTS

Trusted by leading physicians and institutions around the world

Our Tests

At the genomic level, physicians can examine the activity of specific genes inside a tumor – how they interact to drive the behavior of a tumor.

View More Information

Landmark Studies

Data on the validation and utility of MammaPrint and BluePrint for patients with early stage breast cancer.

View More Information

Latest News

The most recent data and news from Agendia to keep you up-to-date on how our tests can support you and your patients.

Read the article

For the US, Puerto Rico, and South America

Agendia Inc. USA
22 Morgan
Irvine, CA 92618
(888) 321-2732
[email protected]


For outside the Americas

Agendia NV
Radarweg 60
1043 NT Amsterdam
The Netherlands
[email protected]
+31 (0)20 462 1510